Arvinas Inc. is a clinical-stage biopharmaceutical company focused on developing novel protein degradation therapies for the treatment of cancer and other diseases. Led by a team of experienced scientists and researchers, Arvinas is pioneering a new approach to drug discovery that has the potential to revolutionize the field of medicine. With a strong pipeline of candidates and strategic partnerships, the company is well-positioned to make a significant impact in the fight against cancer.
Notification